Loading...
CD33 (Siglec-3) Inhibitory Function: Role in the NKG2D/DAP10 Activating Pathway
CD33 (siglec-3), a well-known target in leukemia therapy, is an inhibitory sialoadhesin expressed in human leukocytes of the myeloid lineage and some lymphoid subsets, including NK cells. It may constitute a control mechanism of the innate immune system; nevertheless, its role as an inhibitory recep...
Na minha lista:
| Udgivet i: | J Immunol Res |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Hindawi
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6501159/ https://ncbi.nlm.nih.gov/pubmed/31143782 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/6032141 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|